Chronic imipramine but not bupropion increases arachidonic acid signaling in rat brain: is this related to ‘switching’ in bipolar disorder?
Authors:
Open Access
- 4 November 2008
- journal article
- research article
- Published by Springer Nature in Molecular Psychiatry
- Vol. 15 (6) , 602-614
Abstract
Agents effective against mania in bipolar disorder are reported to decrease turnover of arachidonic acid (AA) in phospholipids and expression of calcium-dependent AA-selective cytosolic phospholipase A2 (cPLA2) in rat brain. In contrast, fluoxetine, an antidepressant that is reported to switch bipolar depressed patients to mania, increases cPLA2 expression and AA turnover in rat brain. We therefore hypothesized that antidepressants that increase switching to mania generally increase cPLA2 and AA turnover in brain. To test this hypothesis, adult male CDF-344 rats were administered imipramine and bupropion, with reported high and low switching rates, respectively, at daily doses of 10 and 30 mg kg−1 i.p., respectively, or i.p. saline (control) for 21 days. Frontal cortex expression of different PLA2 enzymes and AA turnover rates in brain when the rats were unanesthetized were measured. Compared with chronic saline, chronic imipramine but not bupropion significantly increased cortex cPLA2 mRNA activity, protein and phosphorylation, expression of the cPLA2 transcription factor, activator protein-2α (AP-2α) and AA turnover in phospholipids. Protein levels of secretory phospholipase A2, calcium-independent phospholipase A2, cyclooxygenase (COX)-1 and COX-2 were unchanged, and prostaglandin E2 was unaffected. These results, taken with prior data on chronic fluoxetine in rats, suggest that antidepressants that increase the switching tendency of bipolar depressed patients to mania do so by increasing AA recycling and metabolism in brain. Mania in bipolar disorder thus may involve upregulated brain AA metabolism.Keywords
This publication has 91 references indexed in Scilit:
- Chronic N-methyl-d-aspartate administration increases the turnover of arachidonic acid within brain phospholipids of the unanesthetized ratJournal of Lipid Research, 2008
- RETRACTED: Secretory phospholipase A2 IIA is up-regulated by TNF-α and IL-1α/β after transient focal cerebral ischemia in ratBrain Research, 2007
- Resolution of inflammation: the beginning programs the endNature Immunology, 2005
- Distinguishing phospholipase A2 types in biological samples by employing group-specific assays in the presence of inhibitorsProstaglandins & Other Lipid Mediators, 2005
- Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT MethodMethods, 2001
- Interleukin-1 Stimulates Ovarian Phospholipase A2 (PLA2) Expression and Activity: Up-Regulation of Both Secretory and Cytosolic PLA2Endocrinology, 1997
- 5′-Flanking Region Surrounding a Human Cytosolic Phospholipase A2 GeneBiochemical and Biophysical Research Communications, 1994
- Phospholipid fatty acid remodeling in mammalian cellsBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1991
- Different pharmacokinetic and pharmacological effects following acute and chronic treatment with imipramineJournal of Neural Transmission, 1982
- Quantitative analysis of simple lipid classes by thin-layer chromatographyBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1968